AKT1 and hepatocellular carcinoma: E-cadherin expression increased more than 2-fold and Akt expression decreased about 1-fold in the treatment group than in the control group, which proved that ED-71 can inhibit the hepatoma growth by inducing the expression of E-cadherin but suppression of the Akt expression.